Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

XORTX Therapeutics Inc. (XRTX) Form 6-K — Aug 3, 2026

$XRTXForm 6-KFiled Aug 3, 2026, 8:35 PM ET0001171843-26-005158Original filing

XORTX Therapeutics Inc. announced that Anthony Giovinazzo has stepped down from the board of directors for personal reasons and to pursue other interests. Dr. Allen Davidoff, co-CEO, expressed appreciation for Mr.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    XORTX Therapeutics Inc. (XRTX) Form 6-K — Aug 3, 2026: AI Analysis | Signal8